197 related articles for article (PubMed ID: 10878505)
1. CD44 expression in tuberous sclerosis.
Arai Y; Takashima S; Becker LE
Pathobiology; 2000; 68(2):87-92. PubMed ID: 10878505
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
4. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
[TBL] [Abstract][Full Text] [Related]
5. Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos.
Yamanouchi H; Ho M; Jay V; Becker LE
Brain Dev; 1997 Jan; 19(1):21-4. PubMed ID: 9071486
[TBL] [Abstract][Full Text] [Related]
6. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
7. Tuberin expression in ganglioglioma.
Arai Y; Ackerley CA; Becker LE
Ultrastruct Pathol; 2000; 24(2):93-8. PubMed ID: 10808554
[TBL] [Abstract][Full Text] [Related]
8. Glial fibrillary acidic protein in tuberous sclerosis.
Tobo M; Mitsuyama Y; Kaku T
Folia Psychiatr Neurol Jpn; 1983; 37(1):95-100. PubMed ID: 6350129
[TBL] [Abstract][Full Text] [Related]
9. Tuberous sclerosis and epilepsy: role of astrocytes.
Wong M; Crino PB
Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Jansen F; Nellist M; Redeker S; van den Ouweland AM; Spliet WG; van Nieuwenhuizen O; Troost D; Crino PB; Aronica E
Epilepsy Res; 2008 Jan; 78(1):7-21. PubMed ID: 18023148
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of glutamate receptor subunit 2(3) in subependymal giant-cell tumor.
Arai Y; Takashima S; Becker LE
Pediatr Neurol; 2000 Jul; 23(1):37-41. PubMed ID: 10963968
[TBL] [Abstract][Full Text] [Related]
12. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis: a primary pathology of astrocytes?
Sosunov AA; Wu X; Weiner HL; Mikell CB; Goodman RR; Crino PD; McKhann GM
Epilepsia; 2008; 49 Suppl 2():53-62. PubMed ID: 18226172
[TBL] [Abstract][Full Text] [Related]
16. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
18. Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis.
Stefansson K; Wollmann R
Acta Neuropathol; 1980; 52(2):135-40. PubMed ID: 7001853
[TBL] [Abstract][Full Text] [Related]
19. Giant cell astrocytoma of the retina in tuberous sclerosis.
Margo CE; Barletta JP; Staman JA
Retina; 1993; 13(2):155-9. PubMed ID: 8337500
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis: a neuropathological and immunohistochemical (PAP) study.
Nardelli E; De Benedictis G; La Stilla G; Nicolardi G
Clin Neuropathol; 1986; 5(6):261-6. PubMed ID: 3545598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
